|
GeneEd develops new Therapeutic Area e-learning
curricula for the Pharmaceutical Industry covering The Cardiovascular
System, The Respiratory System, and The Gastrointestinal System
San Francisco, CA, September 24, 2002—GeneEd,
Inc., the leading provider of advanced e-learning solutions for
the life science industry, today announced that it has released
52 new courses in three of the most important therapeutic areas
to the Life Science industry: the Cardiovascular System, the Respiratory
System, and the Gastrointestinal System. The comprehensive GeneEd
Therapeutic Area curricula released today represent three of the
most important areas of research, product development, and sales
for major global pharmaceutical organizations. These areas are some
of the most important training subject areas for pharmaceutical
employees. It is critical that pharmaceutical employees have a broad
understanding of the scientific and medical issues within the therapeutic
areas in which they work, whether they are clinical research associates
attempting to accelerate a drug through the drug development pipeline
or pharmaceutical sales forces discussing science with physicians
and clinicians in the field.
The new GeneEd Therapeutic Area curricula include:
Cardiovascular System: Anatomy & Physiology, Coronary Heart
Disease, Dyslipidemia, Heart Failure, Thrombosis, Valvular Disease,
Congenital Diseases, Aneurysm, and Hypertension.
Respiratory System: Anatomy & Physiology, Asthma, Rhinitis,
and Chronic Obstructive Pulmonary Disease (COPD).
Gastrointestinal System: Anatomy & Physiology, Irritable Bowel
Syndrome, Crohn's Disease, Ulcerative Colitis, and Acid-Related
Digestive Disorders (ARDD).
"The release of the Cardiovascular, Respiratory, and Gastrointestinal
curricula represents the first courses in what will be the most
comprehensive scientific and therapeutic area e-learning catalog
ever assembled", said Salil Patel, Chief Scientific Officer
for GeneEd. "These new Therapeutic Area curricula not only
further demonstrate GeneEd's scientific and medical expertise, but
also demonstrate GeneEd's pharmaceutical industry knowledge, as
well as GeneEd's understanding of the critical training needs at
each stage of the drug development process. GeneEd's scientific
e-learning delivered to pharmaceutical employees and sales teams
can accelerate the drug development process by improving workforce
productivity, and can increase sales of pharmaceutical products".
All GeneEd catalog and custom courseware are Continuing Medical
Education (CME) Category One accredited and approved. The GeneEd
Therapeutic Area E-Learning curricula has also been developed to
allow simple technical integration of the courses into a pharmaceutical
organization's Learning Management System (LMS), and all GeneEd
E-Learning courses are SCORM 1.2 compliant.
About GeneEd
GeneEd, Inc. was founded in 1997 to provide life science and healthcare
e-learning solutions for the pharmaceutical, biotechnology, instrument
and medical device, and hospital/HMO industries. GeneEd's Life Science
industry customers include AstraZeneca, Pfizer, the ALZA division
of Johnson&Johnson, Celera, Bio-Rad, and IBM Life Sciences,
amongst many others(http://www.geneed.com/clients/index.html).
GeneEd utilizes the best life science content, combined with advanced
e-learning development technology, to rapidly create basic and advanced
curricula in the areas of genomics, therapeutic area training (for
clinical research, product development, and sales and marketing
teams), computer assisted drug design, drug discovery and development,
pharmacogenomics and clinical genomics, bioinformatics and microarray
informatics, and therapeutic and diagnostic products. GeneEd, Inc.
is a privately held company headquartered in San Francisco, California.
Visit http://www.GeneEd.com for additional information about GeneEd
and its courseware.
|
